LATEST HEALTH NEWS
Results of the PERSPECTIVE trial show one-year outcomes of patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI) treated with Zotarolimus-Eluting Stents (ZES).
from Latest Drug News https://ift.tt/2HyySH7
No comments
Thanks for comment via will connect you within 24 hours.